| abstract |
It is intended to provide compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction. These compositions contain, as the active ingredient, arachidonic acid and/or compounds having arachidonic acid as a constituting fatty acid, in particular, arachidonic acid alcohol esters, or triglycerides, phospholipids or glycolipids containing arachidonic acid as a part or all of the constituting fatty acid(s) thereof. |